Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Vellore
Clinical trial register · India

Clinical Trials in Vellore, 2026

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1120 matching records held by the registry are in this view. Synced 08 Nov 2026, 03:16 UTC
1120
Studies in scope
all four open statuses
608
Recruiting now
open to new participants
218
Lead sponsors
across recruiting studies
Top sites
New Delhi 339 Mumbai 260 Hyderabad 233 Bangalore 199 Pune 186
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novartis Pharmaceuticals4 Genzyme, a Sanofi Company3 Sanofi2 Christian Medical College and Hospital, Ludhiana, India2 Eli Lilly and Company2
Site location
New Delhi339 Mumbai260 Hyderabad233 Bangalore199 Pune186
All 274 locations
Target enrolment
to

Trials with a site in Vellore

34 of 1120 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
Christian Medical College and Hospital, Ludhiana, India
Not applicable
55
Kochi, New Delhi, Ludhiana, Vellore, Kharagpur
2027-09-01
Not yet open
Eli Lilly and Company
Phase 4
50
Bangalore, Hyderabad, Kolkata, Mumbai, New Delhi, Tamil Nadu, Vellore
2026-11
Not yet open
Christian Medical College and Hospital, Ludhiana, India
Not applicable
70
Ludhiana, Vellore, Kharagpur
2026-09-01
Recruiting
Takeda
Phase 3
300
Kochi, Pune, Vellore, Hyderabad, Chandigarh, Delhi
2026-05-21
Recruiting
Sanofi
Phase 3
85
Bengaluru, Mumbai, Pune, Vellore
2025-12-18
Recruiting
Novartis Pharmaceuticals
Phase 3
1,275
Gurugram, Mangalore, Kochi, New Delhi, Chandigarh, Vellore, Hyderabad
2025-11-11
Recruiting
Azafaros B.V.
Phase 3
147
Ernākulam, New Delhi, Jaipur, Vellore
2025-06-30
Recruiting
Azafaros B.V.
Phase 3
72
Ernākulam, New Delhi, Jaipur, Vellore
2025-06-30
Recruiting
Astellas Pharma Global Development, Inc.
Phase 4
100
Patna, Kochi, Mumbai, New Delhi, Dumas, Vellore, Varanasi, Kolkata
2025-06-21
Recruiting
Takeda
Phase 3
225
Ahmedabad, Ernākulam, Mumbai, New Delhi, Ludhiana, Vellore, Ghaziabad, Kolkata
2025-05-06
By invitation
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
NCT06823115Acute Kidney Injury, Fluid Overload, Prematurity Complications, Risk Factors
Indiana University
Observational
8,000
Bengaluru, Chennai, Lucknow, Vellore
2025-03-01
Active, closed
Novartis Pharmaceuticals
Phase 3
180
Gurugram, Mangalore, Nashik, New Delhi, Ludhiana, Vellore, Hyderabad, Lucknow
2025-02-07
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Delhi, Hyderabad, Kolkata, Mumbai, New Delhi, Pune, Varanasi, Vellore
2024-12-12
Recruiting
Panafina, Inc.
Phase 2
36
Kochi, Vellore, Chandigarh, Delhi, New Delhi
2024-06-28
Recruiting
EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics
NCT05979545Blood Stream Infections, Ventilator Associated Pneumonia, Healthcare Associated Infection, Carbapenem-Resistant Enterobacteriaceae Infection
National University of Singapore
Phase 4
1,526
Vellore
2023-12-12
Recruiting
Octapharma
Phase 4
28
Vellore, Bengaluru
2023-11-28
Active, closed
A Study of Zigakibart in Adults With IgA Nephropathy
NCT05852938IgA Nephropathy, Immunoglobulin A Nephropathy
DrugZigakibart
Novartis Pharmaceuticals
Phase 3
383
Hyderabad, Chandigarh, Faridabad, Bengaluru, Trivandrum, Jaipur, Vellore, Lucknow
2023-07-06
Recruiting
P+F Products + Features GmbH
Not applicable
267
Bangalore, Gūrgaon, Jaipur, Kochi, Vellore
2023-07-03
Active, closed
Sanofi
Phase 3
91
Bangalore, Bhubaneswar, Pune-411011, Punjab, Vellore
2023-02-01
Active, closed
Bristol-Myers Squibb
Phase 3
513
Ahmedabad, Hubli, Mysore, Nagpur, Vellore, Hyderabad, Secundarabad
2023-01-12
Active, closed
Celcuity Inc
Phase 3
701
Jaipur, Bangalore, Chandigarh, Kolkata, Navi Mumbai, Vellore
2022-12-08
Active, closed
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 4
144
Chandigarh, Hyderabad, Jaipur, Jodhpur, Lucknow, New Delhi, Rishikesh, Vellore
2022-11-23
Recruiting
International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery
NCT05673499Congenital Disorders, Cerebral Desaturation, Neonatal Surgery
Children's Hospital of Philadelphia
Observational
900
Chandigarh, Vellore
2022-08-12
Recruiting
PRISMA Maternal and Newborn Health Study
NCT05904145Pregnancy, High Risk
George Washington University
Observational
267,897
Vellore
2022-08-01
Recruiting
Transcriptomic Responses for the Identification of Pathogens
NCT04878549Enteric Fever, Acute Febrile Illness, Typhoid, Paratyphoid Fever
University of Sheffield
Observational
2,000
Vellore
2022-05-02
Recruiting
University of California, San Francisco
Not applicable
26,436
Vellore
2021-04-14
Active, closed
Atrasentan in Patients With IgA Nephropathy
NCT04573478IgA Nephropathy, Immunoglobulin A Nephropathy
DrugsAtrasentan·Zigakibart
Novartis Pharmaceuticals
Phase 3
404
Kozhikode, Pune, Vellore, Hyderabad, Secunderabad, Kolkata
2020-12-11
Active, closed
Sarepta Therapeutics, Inc.
Phase 3
160
Ahmedabad, Bengaluru, Hyderabad, Madurai, New Delhi, Pune, Vellore
2020-07-13
Active, closed
Institute of Cancer Research, United Kingdom
Phase 2
184
Trivandrum, Vellore, Kolkata, Mumbai
2020-06-16
Recruiting
Celgene
Phase 2
99
Hyderabad, Mumbai, Nagpur, Noida, Kolkata, Vellore
2019-11-07
Recruiting
Eli Lilly and Company
Phase 3
190
Chennai, New Delhi, Vellore
2019-04-05
Recruiting
Pompe Disease Registry Protocol
NCT00231400Glycogen Storage Disease Type II, Pompe Disease
Genzyme, a Sanofi Company
Observational
2,000
Ahmedabad, Kolkata, Secunderabad, Vellore
2004-09-15
Recruiting
Genzyme, a Sanofi Company
Observational
9,000
Ahmedabad, Kolkata, Secunderabad, Vellore
2001-07-31
Recruiting
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry
NCT00358943Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease
Genzyme, a Sanofi Company
Observational
12,000
Ahmedabad, Jaipur, Kolkata, Mumbai, Secunderabad, Vellore
1991-04-01
Rows per page Showing 1–34 of 34
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 8 November 2026. https://priyalifescience.com/clinical-trials-india/city/vellore

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in India and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,120 studies in total at the last sync on 08 Nov 2026, 03:16 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 34 of those studies with a site in Vellore.

How many clinical trials are recruiting in Vellore?

21 of the 34 studies on this page are recruiting new participants as of the 08 Nov 2026, 03:16 UTC sync. A further 3 have not yet opened recruitment, 9 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Vellore), 34 studies
PhaseStudiesRecruitingShare
Phase 315844.1%
Observational7620.6%
Phase 45314.7%
Not applicable4211.8%
Phase 2328.8%

Most active sponsors

Lead sponsors with the most studies (Vellore)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals41
Genzyme, a Sanofi Company33
Azafaros B.V.22
Christian Medical College and Hospital, Ludhiana, India20
Eli Lilly and Company21
Sanofi21
Takeda22
Astellas Pharma Global Development, Inc.11
Bristol-Myers Squibb10
Celcuity Inc10
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.